Difference between revisions of "Team:BIT/cs3"

 
(10 intermediate revisions by 3 users not shown)
Line 1: Line 1:
<!DOCTYPE HTML>
+
<html>
<html class="no-js" lang="">
+
<!--<![endif]-->
+
 
<head>
 
<head>
 +
<style>
 +
#sideMenu,#top_title{
 +
display:none;
 +
}
 +
#content{
 +
width:100%;margin:0px;padding:0px;
 +
background:#FFF;
 +
}
 +
</style>
 +
 +
 +
<body>
 
<meta charset="utf-8">
 
<meta charset="utf-8">
 
<meta http-equiv="X-UA-Compatible" content="IE=edge">
 
<meta http-equiv="X-UA-Compatible" content="IE=edge">
 
<meta name="viewport" content="width=device-width, initial-scale=1">
 
<meta name="viewport" content="width=device-width, initial-scale=1">
 
<!-- 上述3个meta标签*必须*放在最前面, 任何其他内容都*必须*跟随其后! -->
 
<!-- 上述3个meta标签*必须*放在最前面, 任何其他内容都*必须*跟随其后! -->
 
<title>Dsign - Minimal portfolio Bootstrap template</title>
 
 
  
 
<link rel="stylesheet" href="https://2017.igem.org/Template:BIT/hero-slider-style/CSS?action=raw&amp;ctype=text/css"/>                             
 
<link rel="stylesheet" href="https://2017.igem.org/Template:BIT/hero-slider-style/CSS?action=raw&amp;ctype=text/css"/>                             
Line 15: Line 22:
 
    
 
    
 
     <link rel="stylesheet" href="https://2017.igem.org/Template:BIT/templatemo-style/CSS?action=raw&amp;ctype=text/css"/>                                   
 
     <link rel="stylesheet" href="https://2017.igem.org/Template:BIT/templatemo-style/CSS?action=raw&amp;ctype=text/css"/>                                   
     <!-- Templatemo style -->
+
     <!-- Templatemo style -->
+
 
<!-- Animate.css -->
 
<!-- Animate.css -->
 
<link rel="stylesheet" href="https://2017.igem.org/Template:BIT/animate/CSS?action=raw&amp;ctype=text/css"/>
 
<link rel="stylesheet" href="https://2017.igem.org/Template:BIT/animate/CSS?action=raw&amp;ctype=text/css"/>
Line 28: Line 34:
 
<!-- Theme style  -->
 
<!-- Theme style  -->
 
<link rel="stylesheet" href="https://2017.igem.org/Template:BIT/style/CSS?action=raw&amp;ctype=text/css"/>
 
<link rel="stylesheet" href="https://2017.igem.org/Template:BIT/style/CSS?action=raw&amp;ctype=text/css"/>
<style>
 
  
 
        /*以下CSS用于解决iGEM官网坑爹样式问题*/
 
        body {
 
            height: 100%;
 
            width: 100%;
 
            font-family: 'Helvetica', 'Arial', 'Verdana', sans-serif;
 
            background-color: rgba(242,215,188,0.4);
 
        }
 
        #globalWrapper{
 
            margin: 0;
 
            padding: 0;
 
        }
 
        #content{
 
            width: 100%;
 
            padding: 0;
 
            margin: -12px 0 0;
 
        }
 
 
      #HQ_page p {
 
    font-family: "Arial",Helvetica,sans-serif;
 
    font-size: 13px;
 
    text-align: center;
 
 
        #top_title{
 
            display: none;
 
        }
 
        #sideMenu{
 
            display: none;
 
        }
 
      #content,
 
      .vs-content,
 
      .vs-wrapper section {
 
        background-color: transparent !important;
 
      }
 
      .my-backTop:visited {
 
        color: #F8A886 !important;
 
      }
 
        /*以上CSS用于解决iGEM官网坑爹样式问题*/
 
</style>
 
 
 
</head>
 
</head>
 
<body>
 
<body>
Line 86: Line 51:
 
<div class="col-xs-10 text-right menu-1">
 
<div class="col-xs-10 text-right menu-1">
 
<ul>
 
<ul>
<li class="active"><a href="home.html">Home</a></li>
+
<li class="active"><a href="https://2017.igem.org/Team:BIT">Home</a></li>
 
 
 
<li class="has-dropdown">
 
<li class="has-dropdown">
Line 106: Line 71:
 
</div>
 
</div>
 
</nav>
 
</nav>
      <div id="fh5co-blog">
+
<div id="fh5co-blog">
 
<div class="container">
 
<div class="container">
  <div class="row animate-box">
+
<div class="row animate-box">
 
<div class="col-md-8 col-md-offset-2 text-center fh5co-heading">
 
<div class="col-md-8 col-md-offset-2 text-center fh5co-heading">
<h2>Recent Post</h2>
+
<h2>Market Analysis</h2>
<p>Dignissimos asperiores vitae velit veniam totam fuga molestias accusamus alias autem provident. Odit ab aliquam dolor eius.</p>
+
<p>This year, the final goal of iGEM_Bit team is to provide the potential versatility, precision, and affordability of JACOB—essentially a representation of modularized biomarker detections—to ordinary communities.  
</div>
+
Our plan is to commercialize JACOB to provide warnings for potential disease and develop a self-sustaining facility for production and further research.
 +
From market analysis, we concluded the prominent advantages of JACOB and focused on those to provide more competitive products; from direct interaction with commercial industries, we optimized JACOB's operability and compatibility with the market.
 +
</p>
 +
</div>
 
</div>
 
</div>
            <div>
+
</div>   
                     <div class="cd-full-width">
+
        <div>
 +
                     <div class="container">
 
                         <div class="container-fluid js-tm-page-content" data-page-no="4" data-page-type="gallery">                         
 
                         <div class="container-fluid js-tm-page-content" data-page-no="4" data-page-type="gallery">                         
 
                             <div class="tm-img-gallery-container tm-img-gallery-container-3">
 
                             <div class="tm-img-gallery-container tm-img-gallery-container-3">
Line 130: Line 99:
 
                                         </figure>
 
                                         </figure>
 
                                     </div>
 
                                     </div>
                                    <div class="grid-item">
+
                                  <div class="grid-item">
 
                                         <figure class="effect-ruby">
 
                                         <figure class="effect-ruby">
 
                                             <img src="https://static.igem.org/mediawiki/2017/7/7a/Work-02.jpg" alt="Image" class="img-fluid tm-img">
 
                                             <img src="https://static.igem.org/mediawiki/2017/7/7a/Work-02.jpg" alt="Image" class="img-fluid tm-img">
Line 143: Line 112:
 
                                 </div>                                 
 
                                 </div>                                 
 
                             </div> <!-- .tm-img-gallery-container -->
 
                             </div> <!-- .tm-img-gallery-container -->
                         </div>        
+
                         </div>      
 
                     </div>   
 
                     </div>   
 
</div>
 
</div>
  
 
+
<div id="fh5co-started">
+
  <div class="overlay"></div>
+
+
+
<div id="fh5co-started">
+
<div class="overlay"></div>
+
 
<div class="container">
 
<div class="container">
<div class="row animate-box">
+
  <div class="row animate-box">
 
<div class="col-md-8 col-md-offset-2 text-center fh5co-heading">
 
<div class="col-md-8 col-md-offset-2 text-center fh5co-heading">
 
<h2>Hire Us!</h2>
 
<h2>Hire Us!</h2>
Line 161: Line 125:
 
<p><a href="#" class="btn btn-default btn-lg">Contact Us</a></p>
 
<p><a href="#" class="btn btn-default btn-lg">Contact Us</a></p>
 
</div>
 
</div>
</div>
+
  </div>
 
</div>
 
</div>
</div>
+
        </div>
 +
</div>
 +
       
  
 
<footer id="fh5co-footer" role="contentinfo">
 
<footer id="fh5co-footer" role="contentinfo">
Line 209: Line 175:
 
</div>
 
</div>
 
</footer>
 
</footer>
</div>
+
</div>
  
 
<div class="gototop js-top">
 
<div class="gototop js-top">
 
<a href="#" class="js-gotop"><i class="icon-arrow-up22"></i></a>
 
<a href="#" class="js-gotop"><i class="icon-arrow-up22"></i></a>
 
</div>
 
</div>
 
 
<!-- JS FILES -->  
 
<!-- JS FILES -->  
 
<script src="https://ajax.googleapis.com/ajax/libs/jquery/1.11.3/jquery.min.js?action=raw&amp;ctype=text/jacascript"></script>  
 
<script src="https://ajax.googleapis.com/ajax/libs/jquery/1.11.3/jquery.min.js?action=raw&amp;ctype=text/jacascript"></script>  

Latest revision as of 17:37, 31 October 2017

Market Analysis

This year, the final goal of iGEM_Bit team is to provide the potential versatility, precision, and affordability of JACOB—essentially a representation of modularized biomarker detections—to ordinary communities. Our plan is to commercialize JACOB to provide warnings for potential disease and develop a self-sustaining facility for production and further research. From market analysis, we concluded the prominent advantages of JACOB and focused on those to provide more competitive products; from direct interaction with commercial industries, we optimized JACOB's operability and compatibility with the market.

Hire Us!

Facilis ipsum reprehenderit nemo molestias. Aut cum mollitia reprehenderit. Eos cumque dicta adipisci architecto culpa amet.

Contact Us